Guizhou Sanli Pharmaceutical Co.,Ltd.’s Net Profit Rose 29.2% in 2022

Guizhou Sanli Pharmaceutical Co.,Ltd. (贵州三力制药股份有限公司) (603439.SH) reported a net profit of 191.9 million yuan in 2022, up 29.2% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, up 27.9% year-on-year.

At the end of the reporting period, it had 1.8 billion yuan in total assets and 578.4 million yuan in total liabilities, with a liability-to-asset ratio of 31.8%.